Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Organizational Policy/Guidelines

ASHP Guidelines on Preventing Diversion of Controlled Substances.

Clark J, Fera T, Fortier CR, et al. ASHP Guidelines on Preventing Diversion of Controlled Substances. Am J Health Syst Pharm. 2022;79(24):2279-2306. doi:10.1093/ajhp/zxac246.

Save
Print
December 14, 2022
Clark J, Fera T, Fortier CR, et al. Am J Health Syst Pharm. 2022;79(24):2279-2306.
View more articles from the same authors.

Drug diversion is a system issue that has the potential to disrupt patient access to safe, reliable medications and result in harm. These guidelines offer a structured approach for organizations to develop and implement drug diversion prevention efforts. The strategies submitted focus on foundational, organizational, and individual prevention actions that target risk points across the medication use process such as storage, prescribing, and waste disposal.

Save
Print
Cite
Citation

Clark J, Fera T, Fortier CR, et al. ASHP Guidelines on Preventing Diversion of Controlled Substances. Am J Health Syst Pharm. 2022;79(24):2279-2306. doi:10.1093/ajhp/zxac246.